The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Angioplasty Balloons Market Across 2026–2030?
The angioplasty balloons market size has demonstrated consistent expansion in recent years. It is anticipated to increase from $2.85 billion in 2025 to $2.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.6%. This historical growth can be attributed to factors such as the rising prevalence of coronary artery disease, greater clinical adoption of percutaneous transluminal angioplasty, an increase in hospital catheterization laboratory capacity, the early availability of normal and compliant balloon catheters, and the expanding burden of peripheral artery disease.
The angioplasty balloons market is projected to experience consistent expansion over the upcoming years. It is anticipated to reach $3.47 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 3.9%. This anticipated growth during the forecast period stems from factors such as increasing demand for drug-eluting and specialized balloons, a rise in procedural volumes for peripheral angioplasty, an increase in treatments for complex lesions needing scoring and cutting balloons, the broader embrace of minimally invasive cardiovascular therapies, and greater investments in interventional cardiology infrastructure. Key trends foreseen for this period encompass a wider uptake of drug-eluting balloons for intricate coronary and peripheral lesions, an increasing use of non-compliant and semi-compliant balloons to improve procedural accuracy, a developing preference for scoring and cutting balloons in cases of resistant and calcified stenoses, the broadening scope of minimally invasive angioplasty procedures throughout cardiology and vascular care, and an expanding clinical move towards revascularization via balloons for patients who are not candidates for stenting.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15509&type=smp
What Drivers Are Shaping The Future Growth Of The Angioplasty Balloons Market?
The angioplasty balloons market is anticipated to be boosted by the rising occurrence of cardiovascular diseases moving forward. Cardiovascular disease describes a collection of conditions impacting the heart and blood vessels, frequently resulting in complications like heart attacks or strokes. Its increasing prevalence is linked to inactive lifestyles, unhealthy eating patterns, rising obesity rates, and an aging population. Angioplasty balloons are employed in cardiovascular disease treatment to widen constricted or blocked blood vessels, thereby re-establishing proper blood flow and minimizing the danger of complications such as heart attacks or strokes. For instance, according to data published in September 2024 by the Minnesota Department of Health, a US-based state health agency, approximately 30% of adults in Minnesota reported having high blood pressure in 2023, amounting to nearly 1.4 million people. Additionally, in 2022, hypertensive diseases served as the underlying or contributing cause of death for 14,225 residents, representing almost 28% of all deaths in the state. Consequently, the increasing incidence of cardiovascular diseases is a key driver for the growth of the angioplasty balloons market.
What Segmentation Levels Are Considered In The Angioplasty Balloons Market?
The angioplasty balloons market covered in this report is segmented –
1) By Product Type: Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Material: Non-Compliant, Semi-Compliant
3) By Application: Coronary Angioplasty, Peripheral Angioplasty
4) By End User: Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Normal Balloons: Non-Compliant Balloons, Compliant Balloons
2) By Scoring Balloons: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons
3) By Drug-Eluting Balloons: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons, Everolimus-Eluting Balloons
4) By Cutting Balloons: Balloon Catheters With Cutting Blades, Balloon Catheters With Radial Scoring Elements
What Trends Are Projected To Affect The Angioplasty Balloons Market?
Key companies in the angioplasty balloons market are prioritizing the development of innovative products, such as advanced medical balloon forming systems, to enhance the precision involved in manufacturing high-pressure balloons for critical cardiac procedures. The Advanced Medical Balloon Forming System is a technology engineered for accurately producing compliant medical balloons used within catheter systems. For instance, in June 2024, Interface Catheter Solutions, an innovative catheter technology company based in the US, introduced the BFM-5510 High Force Balloon Forming Machine. This sophisticated benchtop system is specifically designed for manufacturing low- and non-compliant polymer balloons utilized in angioplasty, stent placement, and other essential cardiac procedures. Built upon the BFM-3310 platform, the BFM-5510 HF employs beryllium copper molds to precisely shape extruded balloon tubing, ensuring stringent quality and tight tolerances across a broad spectrum of sizes and shapes. This machine offers superior production capabilities to accommodate the demands for manufacturing larger, thicker, and more complex medical balloons.
Which Leading Firms Are Contributing To The Growth Of The Angioplasty Balloons Market?
Major companies operating in the angioplasty balloons market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Translumina GmbH, Concept Medical Inc
Read the full angioplasty balloons market report here:
https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report
Which Geographic Regions Are Influencing Demand In The Angioplasty Balloons Market?
North America was the largest region in the angioplasty balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angioplasty balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Angioplasty Balloons Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15509&type=smp
Browse Through More Reports Similar to the Global Angioplasty Balloons Market 2026, By The Business Research Company
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Balloon Valvuloplasty Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report
Angio Suites Market Report 2026
https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model